NCT07139106: Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal Thoughts
- State
- Not started
- Phase
- Phase 4
- People
- 12 planned
- Started
- 1 Oct 2026
- Primary completion
- 1 Oct 2028
- Arms
- Ketamine
- Results
- None posted
- 24 Aug 2025: Trial registered